PlainRecalls
FDA Drug Moderate Class II Terminated

Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, NDC: 25021-701-02

Reported: May 15, 2019 Initiated: April 30, 2019 #D-1274-2019

Product Description

Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, NDC: 25021-701-02

Reason for Recall

Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.

Details

Units Affected
75,825 vials
Distribution
Nationwide USA and Puerto Rico
Location
Schaumburg, IL

Frequently Asked Questions

What product was recalled?
Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, NDC: 25021-701-02. Recalled by Sagent Pharmaceuticals Inc. Units affected: 75,825 vials.
Why was this product recalled?
Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 15, 2019. Severity: Moderate. Recall number: D-1274-2019.